All In Biotech

Drug Trial Radar · NCT04329650

Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID-19 Pneumonia

Phase 2, Randomized, Open-label Study to Compare Efficacy and Safety of Siltuximab vs. Corticosteroids in Hospitalized Patients With COVID19 Pneumonia

Last checked: Nov 20, 2026Latest source record: Sep 21, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 163 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

163

Actual

Start

Apr 15, 2020

Primary completion

Feb 26, 2021

Study completion Feb 26, 2021

Sponsor

Lead sponsor
Judit Pich MartínezAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 1, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

In our center up to 25% of the hospitalized patients with COVID-19 progress and need an intensive care unit. It is urgent to find measures that can avoid this progression to severe stages of the disease. We hypothesize that the use of anti-inflammatory drugs used at the time they start hyperinflammation episodes could improve symptoms and prognosis of patients and prevent their progression sufficiently to avoid their need for be admitted to an Intensive Care Unit.

Conditions

  • COVID-19

Interventions

  • SiltuximabDrug

    A single-dose of 11mg/Kg of siltuximab will be administered by intravenous infusion.

  • DexamethasoneDrug

    A dose of 6mg/24 hours of dexamethasone during 10 days will be administered orally or by intravenous infusion.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of patients requiring ICU admission at any time within the study period.Time frame: 29 days

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Hospital Germans Trias i Pujol

    Badalona, Spain

  • Hospital Clínic de Barcelona

    Barcelona, Spain

  • Hospital Universitario de Salamanca

    Salamanca, Spain

  • Hospital Universitari Mútua de Terrassa

    Terrassa, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.